Table 2. Characterization of the dMP formulation.
Encapsulated Agent | Mass Loaded/PLGA (μg/ 100 mg) | Encapsulation Efficiency ± SD (%) | Mass Delivered per Injection ± SD (ng) |
---|---|---|---|
Denatured Insulin | 2580 | 65 ± 7 | 41,500 ± 4,400 |
Vitamin D3 | 10 | 66 ± 3 | 165 ± 10 |
TGF-β1 | 5 | 44 ± 12 | 55 ± 15 |
GM-CSF | 8 | 60 ± 7 | 120 ± 15 |